# Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products

> **NCT00695279** · — · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 41 (actual)

## Conditions studied

- Severe Combined Immunodeficiency
- Malignancy, Hematologic
- Neuroblastoma
- Neoplasm
- Mucopolysaccharidosis I

## Interventions

- **PROCEDURE:** Venipuncture

## Key facts

- **NCT ID:** NCT00695279
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01-04
- **Primary completion:** 2024-10-17
- **Final completion:** 2024-10-17
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2024-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00695279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00695279, "Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products". Retrieved via MORVS 2026-09-30 from https://api.morvs.ai/clinical/NCT00695279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
